Format
Sort by
Items per page

Send to

Choose Destination

Links from BioSystems

Items: 13

1.

Emergence of FGFR family gene fusions as therapeutic targets in a wide spectrum of solid tumours.

Parker BC, Engels M, Annala M, Zhang W.

J Pathol. 2014 Jan;232(1):4-15. Review.

PMID:
24588013
2.

Fibroblast growth factors and their receptors in cancer.

Wesche J, Haglund K, Haugsten EM.

Biochem J. 2011 Jul 15;437(2):199-213. doi: 10.1042/BJ20101603. Review.

PMID:
21711248
3.

Targeting mutant fibroblast growth factor receptors in cancer.

Greulich H, Pollock PM.

Trends Mol Med. 2011 May;17(5):283-92. doi: 10.1016/j.molmed.2011.01.012. Epub 2011 Mar 1. Review.

4.

8p11 myeloproliferative syndrome: a review.

Jackson CC, Medeiros LJ, Miranda RN.

Hum Pathol. 2010 Apr;41(4):461-76. doi: 10.1016/j.humpath.2009.11.003. Review.

PMID:
20226962
5.

Fibroblast growth factor signalling: from development to cancer.

Turner N, Grose R.

Nat Rev Cancer. 2010 Feb;10(2):116-29. doi: 10.1038/nrc2780. Review.

PMID:
20094046
6.

Comprehensive genomic characterization defines human glioblastoma genes and core pathways.

Cancer Genome Atlas Research Network.

Nature. 2008 Oct 23;455(7216):1061-8. doi: 10.1038/nature07385. Epub 2008 Sep 4. Erratum in: Nature. 2013 Feb 28;494(7438):506.

7.

Genetic alterations in the tyrosine kinase transcriptome of human cancer cell lines.

Ruhe JE, Streit S, Hart S, Wong CH, Specht K, Knyazev P, Knyazeva T, Tay LS, Loo HL, Foo P, Wong W, Pok S, Lim SJ, Ong H, Luo M, Ho HK, Peng K, Lee TC, Bezler M, Mann C, Gaertner S, Hoefler H, Iacobelli S, Peter S, Tay A, Brenner S, Venkatesh B, Ullrich A.

Cancer Res. 2007 Dec 1;67(23):11368-76.

8.

Syndromic craniosynostosis: from history to hydrogen bonds.

Cunningham ML, Seto ML, Ratisoontorn C, Heike CL, Hing AV.

Orthod Craniofac Res. 2007 May;10(2):67-81. Review.

PMID:
17552943
9.

Somatic mutations of the protein kinase gene family in human lung cancer.

Davies H, Hunter C, Smith R, Stephens P, Greenman C, Bignell G, Teague J, Butler A, Edkins S, Stevens C, Parker A, O'Meara S, Avis T, Barthorpe S, Brackenbury L, Buck G, Clements J, Cole J, Dicks E, Edwards K, Forbes S, Gorton M, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Jones D, Kosmidou V, Laman R, Lugg R, Menzies A, Perry J, Petty R, Raine K, Shepherd R, Small A, Solomon H, Stephens Y, Tofts C, Varian J, Webb A, West S, Widaa S, Yates A, Brasseur F, Cooper CS, Flanagan AM, Green A, Knowles M, Leung SY, Looijenga LH, Malkowicz B, Pierotti MA, Teh BT, Yuen ST, Lakhani SR, Easton DF, Weber BL, Goldstraw P, Nicholson AG, Wooster R, Stratton MR, Futreal PA.

Cancer Res. 2005 Sep 1;65(17):7591-5.

10.

Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity.

Ibrahimi OA, Zhang F, Eliseenkova AV, Linhardt RJ, Mohammadi M.

Hum Mol Genet. 2004 Jan 1;13(1):69-78. Epub 2003 Nov 12.

PMID:
14613973
11.

Fibroblast growth factor receptors: lessons from the genes.

Burke D, Wilkes D, Blundell TL, Malcolm S.

Trends Biochem Sci. 1998 Feb;23(2):59-62. Review.

PMID:
9538690
12.

FGFR activation in skeletal disorders: too much of a good thing.

Webster MK, Donoghue DJ.

Trends Genet. 1997 May;13(5):178-82. Review.

PMID:
9154000
13.

A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome.

Muenke M, Schell U, Hehr A, Robin NH, Losken HW, Schinzel A, Pulleyn LJ, Rutland P, Reardon W, Malcolm S, et al.

Nat Genet. 1994 Nov;8(3):269-74.

PMID:
7874169

Supplemental Content

Support Center